Yuanxing Gene Technology Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 49

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 10

Yuanxing Gene Technology General Information

Description

Provider of biopharmaceutical CDMO services specializing in advanced therapy manufacturing intended for biotechnology and pharmaceutical clients. The company offers viral vector manufacturing, induced pluripotent stem cell platforms, mRNA therapy production, process development, analytical testing, and integrated manufacturing support, thereby enabling accelerated development and scalable deployment of cell and gene therapies.

Contact Information

Website
www.yxgene.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Building 2, Phase III, Yinxing Zhijie, Xinlan Community
  • Guanlan Subdistrict, Longhua District
  • Shenzhen, Guangdong
  • China
+86 0755
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • 3rd Floor, Building 2, Phase III, Yinxing Zhijie, Xinlan Community
  • Guanlan Subdistrict, Longhua District
  • Shenzhen, Guangdong
  • China
+86 0755

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yuanxing Gene Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 13-May-2021 Completed Generating Revenue
4. Early Stage VC 20-Jul-2020 Completed Generating Revenue
3. Early Stage VC 21-Oct-2019 Completed Generating Revenue
2. Seed Round 03-Dec-2015 Completed Startup
1. Spin-Off 26-Aug-2015 Completed Startup
To view Yuanxing Gene Technology’s complete valuation and funding history, request access »

Yuanxing Gene Technology Patents

Yuanxing Gene Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026228002-A1 Cell reprogramming composition containing circrna and mirna and use thereof Pending 30-Apr-2025

Yuanxing Gene Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Yuanxing Gene Technology Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
CASH Capital Venture Capital Minority
Eastern Link Capital PE/Buyout Minority
Goldport Capital Venture Capital Minority
Green Pine Capital Partners Venture Capital Minority
Oriental Fortune Investment Holdings Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Yuanxing Gene Technology Investments (1)

Yuanxing Gene Technology’s most recent deal was a Seed Round with HYKM BioPharm. The deal was made on 30-Apr-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
HYKM BioPharm 30-Apr-2019 Seed Round Biotechnology
To view Yuanxing Gene Technology’s complete investments history, request access »

Yuanxing Gene Technology FAQs

  • When was Yuanxing Gene Technology founded?

    Yuanxing Gene Technology was founded in 2015.

  • Where is Yuanxing Gene Technology headquartered?

    Yuanxing Gene Technology is headquartered in Shenzhen, China.

  • What is the size of Yuanxing Gene Technology?

    Yuanxing Gene Technology has 49 total employees.

  • What industry is Yuanxing Gene Technology in?

    Yuanxing Gene Technology’s primary industry is Biotechnology.

  • Is Yuanxing Gene Technology a private or public company?

    Yuanxing Gene Technology is a Private company.

  • What is Yuanxing Gene Technology’s current revenue?

    The current revenue for Yuanxing Gene Technology is .

  • Who are Yuanxing Gene Technology’s investors?

    CASH Capital, Eastern Link Capital, Goldport Capital, Green Pine Capital Partners, and Oriental Fortune Investment Holdings are 5 of 10 investors who have invested in Yuanxing Gene Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process